The DOI matches its Crossref record; 361 of the 361 references it cites were found in a registry or an index.
The age of anxiety: role of animal models of anxiolytic action in drug discovery
Open accessAbstract
Anxiety disorders are common, serious and a growing health problem worldwide. However, the causative factors, aetiology and underlying mechanisms of anxiety disorders, as for most psychiatric disorders, remain relatively poorly understood. Animal models are an important aid in giving insight into the aetiology, neurobiology and, ultimately, the therapy of human anxiety disorders. The approach, however, is challenged with a number of complexities. In particular, the heterogeneous nature of anxiety disorders in humans coupled with the associated multifaceted and descriptive diagnostic criteria, creates challenges in both animal modelling and in clinical research. In this paper, we describe some of the more widely used approaches for assessing the anxiolytic activity of known and potential therapeutic agents. These include ethological, conflict‐based, hyponeophagia, vocalization‐based, physiological and cognitive‐based paradigms. Developments in the characterization of translational models are also summarized, as are the challenges facing researchers in their drug discovery efforts in developing new anxiolytic drugs, not least the ever‐shifting clinical conceptualization of anxiety disorders. In conclusion, to date, although animal models of anxiety have relatively good validity, anxiolytic drugs with novel mechanisms have been slow to emerge. It is clear that a better alignment of the interactions between basic and clinical scientists is needed if this is to change. LINKED ARTICLES This article is part of a themed issue on Translational Neuropharmacology. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.164.issue‐4
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The expression of the emotions in man and animals.
Darwin, C. (1872) · J. Murray eBooks · doi:10.1037/10001-000 · Cited by 11,657
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Kirschbaum, C., Pirke, K.-M., & Hellhammer, D. H. (2008) · Neuropsychobiology · doi:10.1159/000119004 · Cited by 6,093
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Role of genotype in the cycle of violence in maltreated children
Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., Taylor, A., & Poulton, R. (2002) · Science · doi:10.1126/science.1072290 · Cited by 4,842
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“Another variant is the novelty-induced hypophagia model in which animals are trained to consume a highly palatable food, such as sweetened milk, and then later presented this food in a novel aversive environment (Soubríe et al., 1975; Gross et al., 2002; Santarelli et al., 2003).”
BackgroundThe price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
Phelps, E. A., & LeDoux, J. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.025 · Cited by 3,203 · cited 4×
“…at a molecular and electrophysiological level, great inroads are being made into delineating the circuits underlying amygdala-dependent fear memory (Phelps and LeDoux, 2005; Sigurdsson et al., 2007; Herry et al., 2008; Ehrlich et al., 2009; Davis et al., 2010; Haubensak et al., 2010; Pape and…”
BackgroundResultInfluentialThe open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
Prut, L., & Belzung, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01272-x · Cited by 3,175
New Introductory Lectures on Psycho-Analysis.
(1935) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1935.02250170221019 · Cited by 3,084
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
The emotional Stroop task and psychopathology
Williams, J. M. G., Mathews, A., & MacLeod, C. (1996) · Psychological Bulletin · doi:10.1037/0033-2909.120.1.3 · Cited by 2,420
The ESEMeD/MHEDEA 2000 Investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00327.x · Cited by 1,819
Plotsky, P. M., & Meaney, M. J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90189-v · Cited by 1,638 · cited 6×
“In particular, while maternal separation has been shown to generate an anxious phenotype (Plotsky and Meaney, 1993; Wigger and Neumann, 1999) in some reports, this is not the case (Lehmann and Feldon, 2000; Millstein and Holmes, 2007; Savignac et al., 2011).”
MethodResultInfluentialPhasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513 · cited 4×
“…the circuits underlying amygdala-dependent fear memory (Phelps and LeDoux, 2005; Sigurdsson et al., 2007; Herry et al., 2008; Ehrlich et al., 2009; Davis et al., 2010; Haubensak et al., 2010; Pape and Pare, 2010; Parsons and Davis, 2011; Sierra-Mercado et al., 2011), which are already being…”
BackgroundResultInfluentialBourin, M., & Hascoët, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01274-3 · Cited by 1,427
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
Crawley, J., & Goodwin, F. K. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90067-2 · Cited by 1,425
Crawley, J. N., Belknap, J. K., Collins, A., Crabbe, J. C., Frankel, W., Henderson, N., Hitzemann, R. J., Maxson, S. C., Miner, L. L., Silva, A. J., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050327 · Cited by 1,372
Hall, C. S. (1934) · Journal of Comparative Psychology · doi:10.1037/h0071444 · Cited by 1,347
Paulus, M. P., & Stein, M. B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.042 · Cited by 1,325 · cited 2×
“More recently, the discovery that insular cortex dysfunction may play a role in anxiety disorders (Paulus and Stein, 2006) has led to the insular cortex-dependent, conditioned taste aversion paradigm becoming more widely used (Bermúdez-Rattoni et al., 2004; Guitton and Dudai, 2004; Mickley et al.,…”
MethodPreventing the return of fear in humans using reconsolidation update mechanisms
Schiller, D., Monfils, M.-H., Raio, C. M., Johnson, D. C., LeDoux, J. E., & Phelps, E. A. (2010) · Nature · doi:10.1038/nature08637 · Cited by 1,248
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Self-citationSierra-Mercado, D., Padilla-Coreano, N., & Quirk, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.184 · Cited by 1,190 · cited 2×
“…Sigurdsson et al., 2007; Herry et al., 2008; Ehrlich et al., 2009; Davis et al., 2010; Haubensak et al., 2010; Pape and Pare, 2010; Parsons and Davis, 2011; Sierra-Mercado et al., 2011), which are already being paralleled with imaging studies in humans (Phelps and LeDoux, 2005; Davis et al., 2010).”
ResultA review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety
Hogg, S. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02126-4 · Cited by 1,164
Fear and anxiety: Animal models and human cognitive psychophysiology
Lang, P. J., Davis, M., & Öhman, A. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00343-8 · Cited by 1,162
Discovering Endophenotypes for Major Depression
Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123
The neuroanatomical and neurochemical basis of conditioned fear
Fendt, M., & Fanselow, M. S. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00016-0 · Cited by 1,092
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Neuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
Pape, H.-C., & Pare, D. (2010) · Physiological Reviews · doi:10.1152/physrev.00037.2009 · Cited by 994
Handley, S. L., & Mithani, S. (1984) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00504983 · Cited by 969
Switching on and off fear by distinct neuronal circuits
Herry, C., Ciocchi, S., Senn, V., Demmou, L., Müller, C., & Lüthi, A. (2008) · Nature · doi:10.1038/nature07166 · Cited by 950 · cited 2×
“Indeed, at a molecular and electrophysiological level, great inroads are being made into delineating the circuits underlying amygdala-dependent fear memory (Phelps and LeDoux, 2005; Sigurdsson et al., 2007; Herry et al., 2008; Ehrlich et al., 2009; Davis et al., 2010; Haubensak et al., 2010; Pape and Pare, 2010; Parso…”
BackgroundResultRupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
(2000) · Cited by 919
Measuring normal and pathological anxiety-like behaviour in mice: a review
Belzung, C., & Griebel, G. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00291-1 · Cited by 912
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult
Gross, C., Zhuang, X., Stark, K., Ramboz, S., Oosting, R., Kirby, L., Santarelli, L., Beck, S., & Hen, R. (2002) · Nature · doi:10.1038/416396a · Cited by 903
Amygdala inhibitory circuits and the control of fear memory
Ehrlich, I., Humeau, Y., Grenier, F., Ciocchi, S., Herry, C., & Lüthi, A. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.026 · Cited by 878 · cited 2×
“Indeed, at a molecular and electrophysiological level, great inroads are being made into delineating the circuits underlying amygdala-dependent fear memory (Phelps and LeDoux, 2005; Sigurdsson et al., 2007; Herry et al., 2008; Ehrlich et al., 2009; Davis et al., 2010; Haubensak et al., 2010; Pape and Pare, 2010; Parso…”
BackgroundResultGogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Localization of a Stable Neural Correlate of Associative Memory
Reijmers, L. G., Perkins, B. L., Matsuo, N., & Mayford, M. (2007) · Science · doi:10.1126/science.1143839 · Cited by 863
A simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
Genetic dissection of an amygdala microcircuit that gates conditioned fear
Haubensak, W., Kunwar, P. S., Cai, H., Ciocchi, S., Wall, N. R., Ponnusamy, R., Biag, J., Dong, H.-W., Deisseroth, K., Callaway, E. M., et al. (2010) · Nature · doi:10.1038/nature09553 · Cited by 840 · cited 2×
“…amygdala-dependent fear memory (Phelps and LeDoux, 2005; Sigurdsson et al., 2007; Herry et al., 2008; Ehrlich et al., 2009; Davis et al., 2010; Haubensak et al., 2010; Pape and Pare, 2010; Parsons and Davis, 2011; Sierra-Mercado et al., 2011), which are already being paralleled with imaging…”
BackgroundResultEarly-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice
Ansorge, M. S., Zhou, M., Lira, A., Hen, R., & Gingrich, J. A. (2004) · Science · doi:10.1126/science.1101678 · Cited by 817 · cited 2×
“, 2010), neurochemical function (Ansorge et al., 2004; Depino et al., 2008), as well as altering early life gene expression (Gross et al.”
BackgroundFile, S. E. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90012-6 · Cited by 815
Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
Ramboz, S., Oosting, R., Amara, D. A., Kung, H. F., Blier, P., Mendelsohn, M., Mann, J. J., Brunner, D., & Hen, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14476 · Cited by 814
Geller, I., & Seifter, J. (1960) · Psychopharmacologia · doi:10.1007/bf00429273 · Cited by 780
Alonso, J., Angermeyer, M. C., & Lépine, J. P. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00325.x · Cited by 758
Shepherd, J. K., Grewal, S. S., Fletcher, A., Bill, D. J., & Dourish, C. T. (1994) · Psychopharmacology · doi:10.1007/bf02244871 · Cited by 739 · cited 3×
“, 1985; Lister, 1987; Rodgers, 1997; Holmes, 2001; Crawley, 2007), elevated zero maze (Lee and Rodgers, 1990; Shepherd et al., 1994), open-field test, light–dark box test (Crawley, 2007), staircase test (Simiand et al.”
BackgroundAnimal Model of Depression: I. Review of Evidence: Implications for Research
McKinney, W. T. (1969) · Archives of General Psychiatry · doi:10.1001/archpsyc.1969.01740200112015 · Cited by 727
The National Comorbidity Survey Replication (NCS‐R): background and aims
Kessler, R. C., & Merikangas, K. R. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.166 · Cited by 723
Elevated anxiety and antidepressant-like responses in serotonin 5-HT 1A receptor mutant mice
Heisler, L. K., Chu, H.-M., Brennan, T. J., Danao, J. A., Bajwa, P., Parsons, L. H., & Tecott, L. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15049 · Cited by 709
Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety
Thomas, A., Burant, A., Bui, N., Graham, D., Yuva-Paylor, L. A., & Paylor, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1466-y · Cited by 698
Avoidance Conditioning with Brief Shock and No Exteroceptive Warning Signal
Sidman, M. (1953) · Science · doi:10.1126/science.118.3058.157 · Cited by 693
Anxiety disorders and comorbid medical illness
Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J. G., Goodwin, R. D., Kubzansky, L., Lydiard, R. B., Massie, M. J., Katon, W., Laden, S. K., et al. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.12.006 · Cited by 668
Animal models of anxiety: an ethological perspective
Rodgers, R. J., Cao, B.-J., Dalvi, A., & Holmes, A. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997000300002 · Cited by 645
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
Vaswani, M., Linda, F. K., & Ramesh, S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00338-x · Cited by 612
Charney, D. S. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190025003 · Cited by 599 · cited 1×
“…experimentally using chemical agents such as caffeine (Nardi et al., 2007), m-chlorophenylpiperazine (mCPP) (Kahn et al., 1990), yohimbine (Charney et al., 1984), CO2 inhalation (Nardi et al., 2007), sodium lactate (Liebowitz et al., 1984; 1985) and isoproterenol (Pohl et al., 1987; Balon…”
MethodGene Targeting: A Practical Approach
Hirst, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 585
Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550
Ventral hippocampal lesions affect anxiety but not spatial learning
Bannerman, D. M., Grubb, M., Deacon, R. M. J., Yee, B. K., Feldon, J., & Rawlins, J. N. P. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00268-1 · Cited by 530 · cited 1×
“In hyponeophagia, tests the level of anxiety-related stimuli is manipulated by using novel food and by conducting the experiment in novel, potentially anxiogenic environments (Bannerman et al., 2002; 2003; Deacon and Rawlins, 2005; Dulawa and Hen, 2005; Finger et al., 2010).”
MethodCrawley, J. N. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90007-1 · Cited by 508
Effects of D-Cycloserine on Extinction: Translation From Preclinical to Clinical Work
Davis, M., Ressler, K., Rothbaum, B. O., & Richardson, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.084 · Cited by 498 · cited 1×
“The efficacy of the NMDA receptor antagonist D-cycloserine in facilitating fear extinction in both the rat fear potentiated startle paradigm and in human acrophobic patients indicate a predictive validity for this approach (Ressler et al., 2004; Ledgerwood et al., 2005; Davis et al., 2006).”
BackgroundStartle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology
Grillon, C. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01665-7 · Cited by 494
Evaluation of marble-burying behavior as a model of anxiety
Njung'e, K., & Handley, S. L. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90590-x · Cited by 487
What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice
Crawley, J. N. (2007) · doi:10.1002/0470119055 · Cited by 474 · cited 8×
“…Rodgers, 1997; Holmes, 2001; Crawley, 2007), elevated zero maze (Lee and Rodgers, 1990; Shepherd et al., 1994), open-field test, light–dark box test (Crawley, 2007), staircase test (Simiand et al., 1984) and mirrored arena (Rodgers, 1997; Rodgers et al., 1997; Belzung and Griebel, 2001; Crawley,…”
BackgroundInfluentialScattoni, M. L., Crawley, J., & Ricceri, L. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.003 · Cited by 473
Models and mechanisms of anxiety: evidence from startle studies
Grillon, C. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1019-1 · Cited by 456
Attentional bias for emotional faces in generalized anxiety disorder
Bradley, B. P., Mogg, K., White, J., Groom, C., & De Bono, J. (1999) · British Journal of Clinical Psychology · doi:10.1348/014466599162845 · Cited by 451
Differences in fear motivated behaviors among inbred mouse strains
Trullas, R., & Skolnick, P. (1993) · Psychopharmacology · doi:10.1007/bf02244948 · Cited by 451
Sternbach, L. H. (1979) · Journal of Medicinal Chemistry · doi:10.1021/jm00187a001 · Cited by 448
Long-term Biobehavioral Effects of Maternal Separation in the Rat: Consistent or Confusing?
Lehmann, J., & Feldon, J. (2000) · Reviews in the Neurosciences · doi:10.1515/revneuro.2000.11.4.383 · Cited by 447
Wigger, A., & Neumann, I. D. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00300-x · Cited by 443
Animal models of ‘anxiety’: Where next?
Rodgers, R. J. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00003 · Cited by 437 · cited 9×
“…paradigms based on approach–avoidance conflict include the elevated plus maze (Handley and Mithani, 1984; Pellow et al., 1985; Lister, 1987; Rodgers, 1997; Holmes, 2001; Crawley, 2007), elevated zero maze (Lee and Rodgers, 1990; Shepherd et al., 1994), open-field test, light–dark box test…”
BackgroundMethodInfluentialThe effects of chronic antidepressant treatment in an animal model of anxiety
Bodnoff, S., Suranyi-Cadotte, B., Aitken, D., Quirion, R., & Meaney, M. (1988) · Psychopharmacology · doi:10.1007/bf00181937 · Cited by 437 · cited 1×
“These include the novelty-suppressed feeding paradigm where animals are presented with normal food in a novel anxiogenic environment, and the latency to begin eating is taken as an index of the anxiety state of the animal (Bodnoff et al., 1988; 1989; Gross et al., 2002).”
BackgroundDulawa, S. C., & Hen, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.017 · Cited by 430
Don't worry ‘B’ happy!: a role for GABAB receptors in anxiety and depression
Cryan, J. F., & Kaupmann, K. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.11.004 · Cited by 421
Self-citationConditioned defensive burying: A new paradigm for the study of anxiolytic agents
Treit, D., Pinel, J. P. J., & Fibiger, H. C. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90219-7 · Cited by 420
Griebel, G., Belzung, C., Perrault, G., & Sanger, D. J. (2000) · Psychopharmacology · doi:10.1007/s002130050038 · Cited by 420
The Discovery of Fluoxetine Hydrochloride (Prozac)
Wong, D. T., Perry, K. W., & Bymaster, F. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1821 · Cited by 418
Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies
Võikar, V., Kõks, S., Vasar, E., & Rauvala, H. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00405-4 · Cited by 416
Maternal separation as a model of brain-gut axis dysfunction
O’Mahony, S. M., Hyland, N. P., Dinan, T. G., & Cryan, J. F. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2010-9 · Cited by 415 · cited 1×
“The results achieved here are heavily dependant on procedural factors such as the length of separation and on subject factors such as gender (O’Mahony et al., 2010).”
BackgroundRickels, K. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820230054005 · Cited by 412
Lactate Provocation of Panic Attacks: I. Clinical and Behavioral Findings
Liebowitz, M. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190038004 · Cited by 397 · cited 2×
“…agents such as caffeine (Nardi et al., 2007), m-chlorophenylpiperazine (mCPP) (Kahn et al., 1990), yohimbine (Charney et al., 1984), CO2 inhalation (Nardi et al., 2007), sodium lactate (Liebowitz et al., 1984; 1985) and isoproterenol (Pohl et al., 1987; Balon et al., 1988; Yeragani et al., 2007).”
BackgroundThe elevated T-maze as an experimental model of anxiety
Graeff, F. G., Ferreira Netto, C., & Zangrossi Jr, H. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00024-4 · Cited by 391
Millstein, R. A., & Holmes, A. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.05.003 · Cited by 391
Monn, J. A., Valli, M. J., Massey, S. M., Wright, R. A., Salhoff, C. R., Johnson, B. G., Howe, T., Alt, C. A., Rhodes, G. A., Robey, R. L., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9606756 · Cited by 390
Defensive burying in rodents: ethology, neurobiology and psychopharmacology
De Boer, S. F., & Koolhaas, J. M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01278-0 · Cited by 389
von Dawans, B., Kirschbaum, C., & Heinrichs, M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.004 · Cited by 387
Lactate Provocation of Panic Attacks: II. Biochemical and Physiological Findings
Liebowitz, M. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790300077010 · Cited by 374
Ultrasounds and maternal behavior in small rodents
Noirot, E. (1972) · Developmental Psychobiology · doi:10.1002/dev.420050410 · Cited by 371
Extending animal models of fear conditioning to humans
Delgado, M. R., Olsson, A., & Phelps, E. A. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.01.006 · Cited by 366
Double dissociation of function within the hippocampus: Spatial memory and hyponeophagia.
Bannerman, D. M., Deacon, R. M. J., Offen, S., Friswell, J., Grubb, M., & Rawlins, J. N. P. (2002) · Behavioral Neuroscience · doi:10.1037/0735-7044.116.5.884 · Cited by 357
Altered anxiety‐related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome
Spencer, C. M., Alekseyenko, O., Serysheva, E., Yuva‐Paylor, L. A., & Paylor, R. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00123.x · Cited by 349
Owen, E. H., Logue, S. F., Rasmussen, D. L., & Wehner, J. M. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00165-6 · Cited by 347
Do animal models of anxiety predict anxiolytic-like effects of antidepressants?
Borsini, F., Podhorna, J., & Marazziti, D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1155-6 · Cited by 347 · cited 9×
“Agents acting on the noradrenergic system, such as tricyclic antidepressants, are, however, less consistent in their anxiolytic effects (Borsini et al., 2002).”
BackgroundMethodInfluentialAnimal models of psychiatric disorders
(2012) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52002-9.00009-7 · Cited by 336
Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects
Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., et al. (2009) · Science · doi:10.1126/science.1175055 · Cited by 328
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328
Long-term potentiation in the amygdala: A cellular mechanism of fear learning and memory
Sigurdsson, T., Doyère, V., Cain, C. K., & LeDoux, J. E. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.022 · Cited by 328
The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist
Jones, B. J., Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J., Oakley, N. R., & Tyers, M. B. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11489.x · Cited by 327
Animal models of mood disorders: recent developments
Cryan, J. F., & Slattery, D. A. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280117733 · Cited by 323
Self-citationA freezing‐like posture to pictures of mutilation
Azevedo, T. M., Volchan, E., Imbiriba, L. A., Rodrigues, E. C., Oliveira, J. M., Oliveira, L. F., Lutterbach, L. G., & Vargas, C. D. (2005) · Psychophysiology · doi:10.1111/j.1469-8986.2005.00287.x · Cited by 320
Modeling madness in mice: one piece at a time
Arguello, P. A., & Gogos, J. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.023 · Cited by 309
The role of substance P in stress and anxiety responses
Ebner, K., & Singewald, N. (2006) · Amino Acids · doi:10.1007/s00726-006-0335-9 · Cited by 306
Associations between anxiety disorders and physical illness
H�rter, M. C., Conway, K. P., & Merikangas, K. R. (2003) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-003-0449-y · Cited by 297
The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic
Blanchard, D. C., Griebel, G., & Blanchard, R. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01276-7 · Cited by 295
Overlapping neural systems mediating extinction, reversal and regulation of fear
Schiller, D., & Delgado, M. R. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.04.002 · Cited by 294
Broekkamp, C. L., Rijk, H. W., Joly-Gelouin, D., & Lloyd, K. L. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90051-8 · Cited by 286
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere, H., Zivkovic, B., Lloyd, K. G., Sanger, D. J., Perrault, G., Langer, S. Z., & Bartholini, G. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24899-6 · Cited by 282
Helton, D. R., Tizzano, J. P., Monn, J. A., Schoepp, D. D., & Kallman, M. J. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37253-2 · Cited by 279
Encyclopedia of Behavioral Neuroscience
(2011) · Choice Reviews Online · doi:10.5860/choice.48-5432 · Cited by 267
Spooren, W. P. J. M., Vassout, A., Neijt, H. C., Kuhn, R., Gasparini, F., Roux, S., Porsolt, R. D., & Gentsch, C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39029-9 · Cited by 266
Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats
Paré, W. P. (1994) · Physiology & Behavior · doi:10.1016/0031-9384(94)90097-3 · Cited by 264
Identification of Glyoxalase-I as a Protein Marker in a Mouse Model of Extremes in Trait Anxiety
Krömer, S. A., Keßler, M. S., Milfay, D., Birg, I. N., Bunck, M., Czibere, L., Panhuysen, M., Pütz, B., Deussing, J. M., Holsboer, F., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0115-05.2005 · Cited by 263
Adriaan Bouwknecht, J., Olivier, B., & Paylor, R. E. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.02.002 · Cited by 256
Sánchez, C., & Meier, E. (1997) · Psychopharmacology · doi:10.1007/s002130050181 · Cited by 255 · cited 1×
“Indeed, the reliance on traditional animal models of anxiety shows little positive effects of SSRIs, and indeed anxiogenic effects are often observed (Sánchez and Meier, 1997; Borsini et al., 2002).”
BackgroundHefner, K., Whittle, N., Juhasz, J., Norcross, M., Karlsson, R.-M., Saksida, L. M., Bussey, T. J., Singewald, N., & Holmes, A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4904-07.2008 · Cited by 248
Ledgerwood, L., Richardson, R., & Cranney, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.023 · Cited by 243
Steimer, T., & Driscoll, P. (2003) · Stress · doi:10.1080/1025389031000111320 · Cited by 242
The effects of chlordiazepoxide and chlorpromazine on a punishment discrimination
Geller, I., Kulak, J. T., & Seifter, J. (1962) · Psychopharmacologia · doi:10.1007/bf00408322 · Cited by 239
Chiu, C.-S., Brickley, S., Jensen, K., Southwell, A., Mckinney, S., Cull-Candy, S., Mody, I., & Lester, H. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3364-04.2005 · Cited by 238
Caffeine, Mental Health, and Psychiatric Disorders
Lara, D. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1378 · Cited by 233
Wesołowska, A., Nikiforuk, A., Stachowicz, K., & Tatarczyńska, E. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.017 · Cited by 230
The history of barbiturates a century after their clinical introduction
Lopez-Munoz, F. J., Udabe, R. U., & Álamo, C. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a800 · Cited by 228
Alonso, J., & Lépine, J. (2007) · PubMed · Cited by 226
From monoamines to genomic targets: a paradigm shift for drug discovery in depression
Wong, M.-L., & Licinio, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1303 · Cited by 225
Bodnoff, S. R., Suranyi-Cadotte, B., Quirion, R., & Meaney, M. J. (1989) · Psychopharmacology · doi:10.1007/bf00442264 · Cited by 221
Behavioral abnormality and pharmacologic response in social isolation-reared mice
Koike, H., Ibi, D., Mizoguchi, H., Nagai, T., Nitta, A., Takuma, K., Nabeshima, T., Yoneda, Y., & Yamada, K. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.028 · Cited by 221
The emotional Stroop effect in anxiety disorders
Becker, E. S., Rinck, M., Margraf, J., & Roth, W. T. (2001) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(01)00055-x · Cited by 218
Schramm, N. L., McDonald, M. P., & Limbird, L. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04875.2001 · Cited by 217
Kash, S. F., Tecott, L. H., Hodge, C., & Baekkeskov, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1698 · Cited by 216
Current Protocols in Pharmacology
(2018) · Current Protocols in Pharmacology · doi:10.1002/(issn)1934-8290 · Cited by 213
Behavioral Addictions Debut in Proposed DSM-V
Holden, C. (2010) · Science · doi:10.1126/science.327.5968.935 · Cited by 206
Cryan, J. F., Kelly, P. H., Chaperon, F., Gentsch, C., Mombereau, C., Lingenhoehl, K., Froestl, W., Bettler, B., Kaupmann, K., & Spooren, W. P. J. M. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066753 · Cited by 206
Self-citationPerry, W., Minassian, A., Paulus, M. P., Young, J. W., Kincaid, M. J., Ferguson, E. J., Henry, B. L., Zhuang, X., Masten, V. L., Sharp, R. F., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.58 · Cited by 204
Landgraf, R., Keßler, M. S., Bunck, M., Murgatroyd, C., Spengler, D., Zimbelmann, M., Nußbaumer, M., Czibere, L., Turck, C. W., Singewald, N., et al. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.003 · Cited by 199
Braun, A. A., Skelton, M. R., Vorhees, C. V., & Williams, M. T. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.09.013 · Cited by 197
Targeted gene mutation approaches to the study of anxiety-like behavior in mice
Holmes, A. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00012-4 · Cited by 197
Time course of attentional bias in anxiety: Emotion and gender specificity
Sass, S. M., Heller, W., Stewart, J. L., Silton, R. L., Edgar, J. C., Fisher, J. E., & Miller, G. A. (2010) · Psychophysiology · doi:10.1111/j.1469-8986.2009.00926.x · Cited by 196
Hippocampal lesions, species-typical behaviours and anxiety in mice
Deacon, R. M. J., & Rawlins, J. N. P. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.05.027 · Cited by 192
Effects of transgenic overproduction of CRH on anxiety‐like behaviour
Van Gaalen, M. M., Stenzel‐Poore, M. P., Holsboer, F., & Steckler, T. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02040.x · Cited by 189
Simiand, J., Keane, P. E., & Morre, M. (1984) · Psychopharmacology · doi:10.1007/bf00432023 · Cited by 189
Davis, M. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90084-f · Cited by 189
Lucki, I., Ward, H. R., & Frazer, A. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23232-3 · Cited by 189
Role of CRF 1 and CRF 2 receptors in fear and anxiety
Takahashi, L. K. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00046-x · Cited by 188
España, J., Giménez-Llort, L., Valero, J., Miñano, A., Rábano, A., Rodriguez-Alvarez, J., LaFerla, F. M., & Saura, C. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.015 · Cited by 187
(2007) · PubMed · Cited by 184
Characterization of stress reactions to the Stroop Color Word Test
Tulen, J. H. M., Moleman, P., van Steenis, H. G., & Boomsma, F. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90204-9 · Cited by 182
Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains
Crawley, J. N., & Davis, L. G. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90087-9 · Cited by 182
Altered fear circuits in 5-HT1A receptor KO mice
Gross, C., Santarelli, L., Brunner, D., Zhuang, X., & Hen, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01041-6 · Cited by 181
Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder
Dunayevich, E., Erickson, J., Levine, L., Landbloom, R., Schoepp, D. D., & Tollefson, G. D. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301531 · Cited by 179
The Vogel conflict test: procedural aspects, γ-aminobutyric acid, glutamate and monoamines
Millan, M. J., & Brocco, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01275-5 · Cited by 177
Holmes, A. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00008-2 · Cited by 175
Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior
Vetter, D. E., Li, C., Zhao, L., Contarino, A., Liberman, M. C., Smith, G. W., Marchuk, Y., Koob, G. F., Heinemann, S. F., Vale, W., et al. (2002) · Nature Genetics · doi:10.1038/ng914 · Cited by 173
Coric, V., Feldman, H. H., Oren, D. A., Shekhar, A., Pultz, J., Dockens, R. C., Wu, X., Gentile, K. A., Huang, S.-P., Emison, E., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20695 · Cited by 172
Evaluation of a rapid technique for detecting minor tranquilizers
Aron, C., Simon, P., Larousse, C., & Boissier, J. R. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90074-8 · Cited by 169
Current animal models of obsessive compulsive disorder: a critical review
Joel, D. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.006 · Cited by 168
Increased Fear Response to Contextual Cues in Mice Lacking the 5-HT1A Receptor
Klemenhagen, K. C., Gordon, J. A., David, D. J., Hen, R., & Gross, C. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300774 · Cited by 167
Feeling Strained? Influence of Genetic Background on Depression-Related Behavior in Mice: A Review
Jacobson, L. H., & Cryan, J. F. (2007) · Behavior Genetics · doi:10.1007/s10519-006-9106-3 · Cited by 167
Self-citationGenetic animal models of anxiety
Finn, D. A., Rutledge-Gorman, M. T., & Crabbe, J. C. (2003) · Neurogenetics · doi:10.1007/s10048-003-0143-2 · Cited by 166
Varty, G. B., Grilli, M., Forlani, A., Fredduzzi, S., Grzelak, M. E., Guthrie, D. H., Hodgson, R. A., Lu, S. X., Nicolussi, E., Pond, A. J., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2143-4 · Cited by 165
Maternal separation with early weaning: A novel mouse model of early life neglect
George, E. D., Bordner, K. A., Elwafi, H. M., & Simen, A. A. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-123 · Cited by 163
Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice
Karolyi, I. J., Burrows, H. L., Ramesh, T., Nakajima, M., Lesh, J., Seong, E., Camper, S. A., & Seasholtz, A. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11595 · Cited by 163
Stress-induced vocalisation in adult animals. A valid model of anxiety?
Sánchez, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01277-9 · Cited by 161
Ohl, F. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-28082-0_2 · Cited by 160
Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice
Merali, Z., Levac, C., & Anisman, H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01827-9 · Cited by 157
Johnson, M. P., Barda, D., Britton, T. C., Emkey, R., Hornback, W. J., Jagdmann, G. E., McKinzie, D. L., Nisenbaum, E. S., Tizzano, J. P., & Schoepp, D. D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2099-9 · Cited by 156
Picazo, O., & Fernández‐Guasti, A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00254-n · Cited by 155
Behavioral Neurobiology of Anxiety and Its Treatment
Stein, M. B., & Steckler, T. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-02912-7 · Cited by 154
Mouse strain differences in autonomic responses to stress
van Bogaert, M. J. V., Groenink, L., Oosting, R. S., Westphal, K. G. C., van der Gugten, J., & Olivier, B. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00143.x · Cited by 150
Anxiety disorders: a comprehensive review of pharmacotherapies
Hoffman, E. J., & Mathew, S. J. (2008) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20041 · Cited by 149 · cited 1×
“Indeed, today SSRIs are first-line therapy for many anxiety disorders (Hoffman and Mathew, 2008).”
BackgroundReduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1
Liu, G., Cai, G.-Q., Cai, Y.-Q., Sheng, Z.-J., Jiang, J., Mei, Z., Zhu-gang, W., Guo, L., & Fei, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301281 · Cited by 141
Spooren, W. P. J. M., Schoeffter, P., Gasparini, F., Kuhn, R., & Gentsch, C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01562-x · Cited by 140
Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations
Lee, C., & Rodgers, R. J. (1990) · Psychopharmacology · doi:10.1007/bf02247133 · Cited by 139
Dissection of behavior and psychiatric disorders using the mouse as a model
Tarantino, L. M., & Bucan, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.953 · Cited by 138
The effects of p-chlorophenylalanine on experimentally induced conflict in the rat
Robichaud, R. C., & Sledge, K. (1969) · Life Sciences · doi:10.1016/0024-3205(69)90427-5 · Cited by 137
Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits
Mombereau, C., Kaupmann, K., Gassmann, M., Bettler, B., van der Putten, H., & Cryan, J. F. (2005) · Neuroreport · doi:10.1097/00001756-200502280-00021 · Cited by 135
Self-citationmGluR7 facilitates extinction of aversive memories and controls amygdala plasticity
Fendt, M., Schmid, S., Thakker, D. R., Jacobson, L. H., Yamamoto, R., Mitsukawa, K., Maier, R., Natt, F., Hüsken, D., Kelly, P. H., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002073 · Cited by 135
Self-citationDekeyne, A., la Cour, C. M., Gobert, A., Brocco, M., Lejeune, F., Serres, F., Sharp, T., Daszuta, A., Soumier, A., Papp, M., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1177-9 · Cited by 135
The Genes and Brains of Mice and Men
Tecott, L. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.646 · Cited by 133
Onaivi, E. S., & Martin, B. R. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90047-x · Cited by 132
Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice
Lähdesmäki, J., Sallinen, J., MacDonald, E., Kobilka, B. K., Fagerholm, V., & Scheinin, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00185-9 · Cited by 131
Steimer, T. J., la Fleur, S. E., & Schulz, P. (1997) · Behavior Genetics · doi:10.1023/a:1021448713665 · Cited by 130
Kłodzińska, A., Chojnacka-Wójcik, E., Pałucha-Poniewiera, A., Brański, P., Popik, P., & Pilc, A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00066-0 · Cited by 129
General and social anxiety in the BTBR T+ tf/J mouse strain
Pobbe, R. L. H., Defensor, E. B., Pearson, B. L., Bolivar, V. J., Blanchard, D. C., & Blanchard, R. J. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.039 · Cited by 127
Resistance to Early-Life Stress in Mice: Effects of Genetic Background and Stress Duration
Savignac, H. M., Dinan, T. G., & Cryan, J. F. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00013 · Cited by 126
Self-citationSoubri�, P., Kulkarni, S., Simon, P., & Boissier, J. R. (1975) · Psychopharmacology · doi:10.1007/bf00429062 · Cited by 124
Shibata, S., Yamashita, K., Yamamoto, E., Ozaki, T., & Ueki, S. (1989) · Psychopharmacology · doi:10.1007/bf00442003 · Cited by 122
Behavioral differences among 129 substrains: Implications for knockout and transgenic mice.
Cook, M. N., Bolivar, V. J., Leussis, M. P., & Flaherty, L. (2002) · Behavioral Neuroscience · doi:10.1037/0735-7044.116.4.600 · Cited by 122
Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders
Ebner, K., Sartori, S. B., & Singewald, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168074 · Cited by 121
Varty, G. B. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00313-5 · Cited by 119
Direct effects of diazepam on emotional processing in healthy volunteers
Murphy, S. E., Downham, C., Cowen, P. J., & Harmer, C. J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1082-2 · Cited by 119
Ohl, F., Sillaber, I., Binder, E., Keck, M. E., & Holsboer, F. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00017-6 · Cited by 117
Griebel, G., Blanchard, D. C., Agnes, R. S., & Blanchard, R. J. (1995) · Psychopharmacology · doi:10.1007/bf02246145 · Cited by 116
Vinkers, C. H., van Bogaert, M. J. V., Klanker, M., Korte, S. M., Oosting, R. S., Hanania, T., Hopkins, S. C., Olivier, B., & Groenink, L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.097 · Cited by 115
Moser, P. C., Tricklebank, M. D., Middlemiss, D. N., Mir, A. K., Hibert, M., & Fozard, J. R. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14706.x · Cited by 115
Cited by
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Self-citationClarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
Self-citationAnimal models of anxiety disorders and stress
Campos, A. C., Fogaca, M. V., Aguiar, D. C., & Guimaraes, F. S. (2013) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2013-1139 · Cited by 471
Belzung, C., & Lemoine, M. (2011) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-1-9 · Cited by 438
Savignac, H. M., Kiely, B., Dinan, T. G., & Cryan, J. F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12427 · Cited by 418
Metadata
- Authors
- Cryan, J. F., & Sweeney, F. F.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-10
- Volume
- 164
- Issue
- 4
- Pages
- 1129-1161
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1545745337
- Cited by
- 316
- References
- 361
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.